chr3-121993204-A-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001199799.2(ILDR1):​c.1545T>G​(p.Leu515Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.731 in 1,612,864 control chromosomes in the GnomAD database, including 433,612 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.74 ( 42118 hom., cov: 33)
Exomes 𝑓: 0.73 ( 391494 hom. )

Consequence

ILDR1
NM_001199799.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.604

Publications

36 publications found
Variant links:
Genes affected
ILDR1 (HGNC:28741): (immunoglobulin like domain containing receptor 1) This gene encodes a protein that contains an immunoglobulin-like domain. The encoded protein may function as a multimeric receptor at the cell surface. The expression of this gene may be a diagnostic marker for cancer progression. Alternatively spliced transcript variants encoding multiple protein isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
ILDR1 Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 42
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 3-121993204-A-C is Benign according to our data. Variant chr3-121993204-A-C is described in ClinVar as Benign. ClinVar VariationId is 44141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.604 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.901 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ILDR1NM_001199799.2 linkc.1545T>G p.Leu515Leu synonymous_variant Exon 7 of 8 ENST00000344209.10 NP_001186728.1 Q86SU0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ILDR1ENST00000344209.10 linkc.1545T>G p.Leu515Leu synonymous_variant Exon 7 of 8 1 NM_001199799.2 ENSP00000345667.5 Q86SU0-1

Frequencies

GnomAD3 genomes
AF:
0.739
AC:
112440
AN:
152050
Hom.:
42078
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.818
Gnomad AMI
AF:
0.609
Gnomad AMR
AF:
0.601
Gnomad ASJ
AF:
0.678
Gnomad EAS
AF:
0.923
Gnomad SAS
AF:
0.794
Gnomad FIN
AF:
0.714
Gnomad MID
AF:
0.693
Gnomad NFE
AF:
0.715
Gnomad OTH
AF:
0.703
GnomAD2 exomes
AF:
0.726
AC:
179987
AN:
247786
AF XY:
0.729
show subpopulations
Gnomad AFR exome
AF:
0.820
Gnomad AMR exome
AF:
0.581
Gnomad ASJ exome
AF:
0.678
Gnomad EAS exome
AF:
0.927
Gnomad FIN exome
AF:
0.724
Gnomad NFE exome
AF:
0.715
Gnomad OTH exome
AF:
0.704
GnomAD4 exome
AF:
0.730
AC:
1066660
AN:
1460696
Hom.:
391494
Cov.:
59
AF XY:
0.732
AC XY:
531559
AN XY:
726598
show subpopulations
African (AFR)
AF:
0.820
AC:
27436
AN:
33470
American (AMR)
AF:
0.583
AC:
25944
AN:
44516
Ashkenazi Jewish (ASJ)
AF:
0.676
AC:
17649
AN:
26110
East Asian (EAS)
AF:
0.938
AC:
37228
AN:
39678
South Asian (SAS)
AF:
0.780
AC:
67147
AN:
86128
European-Finnish (FIN)
AF:
0.725
AC:
38659
AN:
53312
Middle Eastern (MID)
AF:
0.661
AC:
3812
AN:
5768
European-Non Finnish (NFE)
AF:
0.724
AC:
804793
AN:
1111410
Other (OTH)
AF:
0.730
AC:
43992
AN:
60304
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
16625
33250
49874
66499
83124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20070
40140
60210
80280
100350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.740
AC:
112530
AN:
152168
Hom.:
42118
Cov.:
33
AF XY:
0.737
AC XY:
54851
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.817
AC:
33966
AN:
41550
American (AMR)
AF:
0.600
AC:
9174
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.678
AC:
2354
AN:
3470
East Asian (EAS)
AF:
0.923
AC:
4775
AN:
5176
South Asian (SAS)
AF:
0.794
AC:
3827
AN:
4822
European-Finnish (FIN)
AF:
0.714
AC:
7547
AN:
10574
Middle Eastern (MID)
AF:
0.697
AC:
205
AN:
294
European-Non Finnish (NFE)
AF:
0.715
AC:
48633
AN:
67976
Other (OTH)
AF:
0.709
AC:
1495
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1512
3024
4537
6049
7561
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.724
Hom.:
116401
Bravo
AF:
0.734
Asia WGS
AF:
0.868
AC:
3017
AN:
3478
EpiCase
AF:
0.710
EpiControl
AF:
0.706

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jul 02, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Leu515Leu in Exon 07 of ILDR1: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence, and has been identified in 28.8% (2021/7018) of European American chromosomes from a broad population by the NHLBI Exome Sequen cing Project (http://evs.gs.washington.edu/EVS; dbSNP rs2877561). -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 42 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
12
DANN
Benign
0.37
PhyloP100
0.60
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2877561; hg19: chr3-121712051; COSMIC: COSV56552211; API